Capital Injection
An investment of capital into a company, subsidiary, or project to boost its liquidity, strengthen its balance sheet, or fund expansion.
A capital injection is the process of introducing new funds into a business, subsidiary, or project to improve its financial position. This cash or asset transfer typically comes from a parent company, private equity investors, venture capitalists, or a government entity. Unlike organic revenue generation, a capital injection is an external funding event designed to rapidly boost liquidity, strengthen the balance sheet, or fund strategic initiatives. Investors analyze capital injections based on the recipient's circumstances. When a parent company injects capital into a high-growth subsidiary, it signals confidence in the unit's expansion plans, such as building new facilities or entering new markets. Conversely, if a struggling company requires an emergency capital injection to avoid default, it often signals deep operational or liquidity distress. For public market investors, the structure of the injection is critical. If the capital is raised by issuing new equity, it can dilute the ownership percentage and earnings per share of existing shareholders. If it is structured as debt or convertible notes, it increases the company's leverage and future interest obligations, which can alter the risk profile of the stock.
Company A has 10 million shares outstanding and needs to fund a new factory. It secures a capital injection of $50 million from an institutional investor by issuing 2 million new shares at $25 each. This increases the total shares outstanding to 12 million, diluting existing shareholders' ownership by approximately 16.7% while increasing the company's cash balance by $50 million.